MiRNA encoded PTEN’s impact on clinical-pathological features and prognosis in osteosarcoma: A systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304543 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Edward Kurnia Setiawan Limijadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Osteosarcoma, MicroRNAs, Bone Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Osteosarcoma (OSC) is considered one of the most common malignant bone tumours in adolescents. Due to OSC’s poor prognosis, a comprehensive approach to exploring these aspects is highly needed to improve the survival probability of OSC. In this study, we tried to explore the significance of miRNA-encoded PTEN for clinical-pathological features and prognostic value in OSC.
Method
We performed this systematic review and meta-analysis using articles and sources published between 2013 and 2023 from six databases (Scopus, PubMed, ProQuest, Science Direct, Sage Pub, and Cochrane). Included studies were clinical cross-sectional studies. Other study designs, articles not written in English, without full text, and not relevant—were excluded. Then, ROBINS-I is used to evaluate the distance. The results are constructed according to the PICOS criteria in a table. The expression of miRNA related to OSC is assessed in the meta-analysis as the main outcome to determine its ability as a diagnostic and prognostic agent for OSC. This systematic review followed the PRISMA guidelines.
Results
A total of 17 studies were included in the final screening. The meta-analysis showed significantly increased (p < 0.00001) miRNA expression in patients with OSC compared to healthy controlled with pooled md (2.85) (95% CI: 2.69, 3.02; I 2 = 22%, p = 0.20), the high inverse correlation (p < 0.001) between miRNA and PTEN expression was shown as mean effect size (-0.681) (95% CI: -0.787, -0.536; I 2 = 75%, p < 0.0001), and the prognostic evaluation of OS was significantly increased in low expression miRNA (p < 0.00001) with pooled OR.
Conclusion
Fifteen miRNAs from 17 studies were found, and together with PTEN expression, they may serve as potential prognostic biomarkers for OSC. High-level levels of miRNA expression are correlated with low PTEN expression, leading to a bad prognosis for OSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
- Department of Orthopaedic Surgery, Faculty of Medicine, Universitas Diopnegoro, Semarang, Indonesia.
- Kariadi General Hospital, Semarang, Indonesia.
- Departement of Medicine, Faculty of Medicine, Universitas Diponegoro, Semarang, Indonesia.
ORCID-Profile: Danendra Rakha Putra Respati
Zitieren
APA
Limijadi, E. K. S., Novriansyah, R., Respati, D. R. P., & Tjandra, K. C. (2024). MiRNA encoded PTEN’s impact on clinical-pathological features and prognosis in osteosarcoma: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0304543
Vancouver
Limijadi EKS, Novriansyah R, Respati DRP, Tjandra KC. MiRNA encoded PTEN’s impact on clinical-pathological features and prognosis in osteosarcoma: A systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0304543
BibTeX
@article{Limijadi2024,
author = {Limijadi, Edward Kurnia Setiawan and Novriansyah, Robin and Respati, Danendra Rakha Putra and Tjandra, Kevin Christian},
title = {MiRNA encoded PTEN’s impact on clinical-pathological features and prognosis in osteosarcoma: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304543}
}
EUVIMED